SLS
SELLAS Life Sciences Group Inc. Common Stock
$1.650+0.000 (0.000%)
Reaalajas hind
Hinnagraafik
Loading Chart...
Põhinäitajad
Turunäitajad
Avatud
$1.650
Kõrge
$1.650
Madal
$1.650
Maht
2.61M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
GlobeNewswire
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for
Vaata rohkem
GlobeNewswire
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m
Vaata rohkem
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.